Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
about
Targeted Therapy in Oropharyngeal Squamous Cell Carcinoma: The Implications of HPV for TherapyHPV in oropharyngeal cancer: the basics to know in clinical practiceDEK associates with tumor stage and outcome in HPV16 positive oropharyngeal squamous cell carcinoma.HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53Increasing incidence of base of tongue cancers from 2000 to 2010 due to HPV: the largest demographic study of 210 Danish patients.Prevalence of human papillomavirus in oropharyngeal squamous cell carcinoma in the United States across time.Meta-analysis of survival in patients with HNSCC discriminates risk depending on combined HPV and p16 status.Comparison of Polymerase Chain Reaction and Immunohistochemistry Assays for Analysing Human Papillomavirus Infection in Oral Squamous Cell Carcinoma.p16, HPV, and Cetuximab: What Is the Evidence?Role of mucosal high-risk human papillomavirus types in head and neck cancers in central India.p16(INK4a) /Ki-67 co-expression specifically identifies transformed cells in the head and neck region.Human papillomavirus related oropharyngeal cancer.Is immunohistochemical evaluation of p16 in oropharyngeal cancer enough to predict the HPV positivity?Radiologic Differences between Human Papillomavirus-Related and Human Papillomavirus-Unrelated Oropharyngeal Carcinoma on Diffusion-Weighted Imaging.Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction.Differences in survival outcome between oropharyngeal and oral cavity squamous cell carcinoma in relation to HPV status.Diagnosis of HPV-driven head and neck cancer with a single test in routine clinical practice.Human papillomavirus and oropharyngeal squamous cell carcinoma: a New Zealand cohort study.Double positivity for HPV DNA/p16 in tonsillar and base of tongue cancer improves prognostication: Insights from a large population-based study.Prevalence of HPV infection in head and neck carcinomas shows geographical variability: a comparative study from Brazil and Germany.Quantitative diffusion-weighted MRI parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.Combination of p16(INK4a) /Ki67 immunocytology and HPV polymerase chain reaction for the noninvasive analysis of HPV involvement in head and neck cancer.A high and increasing HPV prevalence in tonsillar cancers in Eastern Denmark, 2000-2010: the largest registry-based study to date.Human papilloma virus and survival of oropharyngeal cancer patients treated with surgery and adjuvant radiotherapy.Beware of the dangers along the path towards the diagnosis of HPV-driven oropharyngeal squamous cell carcinoma.Differentiated squamous intraepithelial neoplasia associated with squamous cell carcinoma of the anal canal.Low prevalence of HPV-driven head and neck squamous cell carcinoma in North-East Italy.Poor prognosis in human papillomavirus-positive oropharyngeal squamous cell carcinomas that overexpress hypoxia inducible factor-1α.
P2860
Q26824925-6DFA255C-4528-4E07-B420-9978234BF514Q26853669-057E52A9-3E6C-4CEC-A1A5-2CD3E8D2E6F4Q33618700-E1023834-9211-43E9-873B-778249FA86F0Q35475401-4B0F5678-1854-45DA-B7EC-4BE74CC2071CQ36286630-5096891D-4912-4569-9F33-D4079A758B01Q37727556-9D1DE1FC-E0E2-4283-807F-5C71DED305E8Q38557897-B067F7FB-5634-43D6-B5AA-AC7821B3EC4CQ38648823-792D7DA7-E6CA-4477-8F65-1B4B41E70B0BQ38773776-61A655EF-BEA4-4E4F-BBFC-012D4F8CEEE8Q38859808-27F4FA96-D08A-486E-B5D4-1210C738684FQ38967902-2F0278BA-D922-46D8-B9B6-FC7F9BD32CE9Q40152615-9FB2B2D7-6D56-488D-8DD7-DC1C281BD798Q40219648-32937909-1C78-44D2-969C-D4FE1B96ABDBQ40314585-55C901C4-0D74-4617-B2DC-585DBBCAB49AQ40360475-2B456B11-F774-4A86-B27C-C879873A1830Q40432912-2034EB0F-D316-4128-B2AA-D72B8817342DQ40504994-DACE58EB-A198-439F-AD38-09C44B3D28FAQ40534462-C73040DA-BE29-4877-B577-90B092DF57E4Q40571255-B9D26F39-8AAB-4B28-82FE-68C3B65D7D6DQ41372801-6F549CDA-812B-437F-86D6-1C19218BA688Q41462091-D0859ED9-21E7-441F-AE7A-10F28B037462Q41564660-694BF6A9-7363-49F4-99BE-B7E765C4185FQ41715956-0ECB2EA3-C5C1-4FDE-8FC7-94070BEA1A35Q42215642-11F982E6-5ADA-4E8C-911A-FCF871FAD1EFQ42292536-715A78D8-AC32-4E75-915B-5CA309D75B35Q42482817-D0ABA816-E81C-4EDC-8773-0611017DB675Q47599117-864ADBE7-F027-4D62-9A67-DE9AB4967CFBQ52143221-6C2FE1A2-4E2A-4932-B3AC-8CFE0BE22C63
P2860
Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Molecular characterization of ...... tive oropharyngeal carcinomas.
@en
Molecular characterization of ...... tive oropharyngeal carcinomas.
@nl
type
label
Molecular characterization of ...... tive oropharyngeal carcinomas.
@en
Molecular characterization of ...... tive oropharyngeal carcinomas.
@nl
prefLabel
Molecular characterization of ...... tive oropharyngeal carcinomas.
@en
Molecular characterization of ...... tive oropharyngeal carcinomas.
@nl
P2093
P2860
P356
P1476
Molecular characterization of ...... ative oropharyngeal carcinomas
@en
P2093
Albertus T Hesselink
Arjen Brink
Birgit I Witte
Boudewijn J M Braakhuis
C René Leemans
Daniëlle A M Heideman
Derakshan Beekzada
Michelle M Rietbergen
Peter J F Snijders
Ruud H Brakenhoff
P2860
P304
P356
10.1002/IJC.28580
P577
2013-11-19T00:00:00Z